Live tape
Top 8, mentions 7d10,073TSLA2,067 mentions▲ +0.05GOOGL1,610 mentions▲ +0.04NVDA1,232 mentions▲ +0.07CRWV1,217 mentions▲ +0.03SPCX1,105 mentions▲ +0.07QQQ1,076 mentions▲ +0.04META891 mentions▲ +0.05NBIS875 mentions▲ +0.06

Equity · Healthcare

INCY

NASDAQ

Incyte Corporation

$117 0.00% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for INCY to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $23.4B
P/E (TTM) 16.5
52-week range $67.40 – $119
Avg volume 349.6K

as of Jul 17, 2026

INCY insider trades

SEC Form 4 · last 90 days · newest reported trade 15 Sep 2026
Open-market buys 0
Open-market sells 8
Net sold $14.67M
Non-trade filings 9
Date Insider Type Shares Value
15 Sep 2026 CAGNONI PABLO J President, Global Head of R&D Sell 23,218 $2.80M
19 Aug 2026 CAGNONI PABLO J President, Global Head of R&D Sell 10,801 $1.36M
12 Aug 2026 CAGNONI PABLO J President, Global Head of R&D Sell 10,803 $1.30M
05 Aug 2026 CAGNONI PABLO J President, Global Head of R&D Sell 10,640 $1.31M
05 Aug 2026 Mayes Patrick A EVP & Chief Scientific Officer Sell 2,207 $274K
03 Aug 2026 Mayes Patrick A EVP & Chief Scientific Officer Sell 6,055 $729K
31 Jul 2026 CAGNONI PABLO J President, Global Head of R&D Sell 15,888 $1.90M
31 Jul 2026 Mayes Patrick A EVP & Chief Scientific Officer Sell 41,899 $5.01M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Oct 2026 Heeson Lee EVP, Head of Incyte Intl Tax withheld 463 $54K
30 Sep 2026 Clancy Paul J Director Award 203 $25K
30 Sep 2026 HARRIGAN EDMUND Director Award 206 $25K
22 Sep 2026 Gardner David H EVP, Chief Strategy Officer Tax withheld 920 $117K
15 Sep 2026 CAGNONI PABLO J President, Global Head of R&D Option exercise 23,218 $1.54M
25 Aug 2026 Basi Ramitpal K EVP, Human Resources Tax withheld 504 $65K
05 Aug 2026 Mayes Patrick A EVP & Chief Scientific Officer Option exercise 2,207 $235K
03 Aug 2026 Mayes Patrick A EVP & Chief Scientific Officer Option exercise 6,055 $638K
31 Jul 2026 Mayes Patrick A EVP & Chief Scientific Officer Option exercise 37,089 $2.73M

INCY reported financials

SEC EDGAR XBRL SEC EDGAR

INCY reported revenue of $5.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was $1.3B.

Figure Reported Period
Revenue $5.1B 31 Dec 2025 fiscal year
Net income $1.3B 31 Dec 2025 fiscal year
Diluted EPS $6.41 31 Dec 2025 fiscal year
Total assets $7.3B 31 Mar 2026 at period end
Total equity $5.6B 31 Mar 2026 at period end

INCY earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $1.47 —
31 Dec 2025 FY 2025 $6.41 —
30 Sep 2025 Q3 2025 $2.11 —
30 Jun 2025 Q2 2025 $2.04 —
31 Mar 2025 Q1 2025 $0.80 —
31 Dec 2024 FY 2024 $0.15 —
30 Sep 2024 Q3 2024 $0.54 —
30 Jun 2024 Q2 2024 −$2.04 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

INCY institutional holders

SEC Form 13F SEC EDGAR

13 of the 45 institutional funds we track reported a INCY position for the quarter ended 30 Jun 2026 — a combined $5.0B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) +0.1% shares 30,762,330 $3.5B
AQR Capital Management Held (±25%) −8.4% shares 5,320,901 $603.2M
Renaissance Technologies Held (±25%) −3.8% shares 3,512,132 $398.1M
Two Sigma Investments Added +381.7% shares 2,003,559 $227.1M
Marshall Wace Held (±25%) +4.5% shares 1,310,154 $148.5M
Man Group Held (±25%) +2.4% shares 952,941 $108.0M
Bridgewater Associates Added +29.1% shares 168,253 $19.1M
Citadel Advisors Added +191.2% shares 143,509 $16.3M
Fisher Asset Management Held (±25%) +21.5% shares 137,018 $15.5M
Millennium Management Trimmed −52.1% shares 82,812 $9.4M

Showing the 10 largest of 13 reported positions. The figures above count all of them.

INCY fails-to-deliver

SEC CNS data SEC

On 24 Sep 2026, 1 shares of INCY failed to deliver (about $125).

Settlement date Shares failed Notional % of shares out
24 Sep 2026 1 $125 <0.001%
21 Sep 2026 10,917 $1.4M 0.005%
16 Sep 2026 60 $7K <0.001%
10 Sep 2026 62,826 $7.9M 0.031%
09 Sep 2026 63,477 $7.9M 0.032%
08 Sep 2026 95,688 $12.1M 0.048%

Congressional trades in INCY

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in INCY is a sale by Robert P. Bresnahan, Jr. (house, PA), dated 15 May 2025.

Date Member Type Amount
15 May 2025 filed 31 May 2025 Robert P. Bresnahan, Jr. house · Republican–PA Sale $1K–$15K
06 Mar 2023 filed 17 Apr 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings